This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Phuoc Tran: Innovator in Ablative Radiotherapy
Introduction
Phuoc Tran is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of medicine, particularly in the area of cancer treatment. His innovative work focuses on enhancing the effectiveness of radiotherapy through the use of specific compounds.
Latest Patents
Phuoc Tran holds 1 patent for his invention titled "Compounds and methods of use in ablative radiotherapy." This patent introduces the compound RK-33, which acts as an inhibitor of the DEAD box helicase DDX3 in mammalian cells. RK-33 is designed to serve as a radiation dose sensitizer for patients suffering from proliferative diseases, such as cancer, who are undergoing radiation therapy. The patent also outlines methods for treating these diseases using a combination of RK-33 and advanced radiotherapy techniques, including stereotactic ablative radiotherapy (SABR).
Career Highlights
Phuoc Tran is affiliated with Johns Hopkins University, where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, providing new avenues for treatment that could improve patient outcomes.
Collaborations
Phuoc Tran collaborates with Venu Raman, a fellow researcher, to further explore the applications of RK-33 and its potential benefits in clinical settings.
Conclusion
Phuoc Tran's innovative contributions to ablative radiotherapy exemplify the critical role of inventors in advancing medical science. His work not only enhances treatment options for cancer patients but also paves the way for future research in this vital area.